	Sep 2025	Jun 2025	Sep 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	7.87	18.78	12.90	-58.1%	-39.0%
Operating Profit Qtr	-65.72	-52.08	-102.91	-26.2%	36.1%
Net Profit Qtr	-75.85	-51.87	-107.33	-46.2%	29.3%
Earning Per Share Adjusted latest Qtr	-2.34	-1.60	-3.31	-46.2%	29.3%

* Consolidated data

Detailed Results

Sun Pharma Advanced Research Company Ltd.

10 Nov 2025

133.51

-1.84%

Board Meeting

Sun Pharma Advanced Research Company Ltd - 532872 - Board Meeting Outcome for Outcome Of The …

BSE India

Outcome of the Board Meeting for approval of unaudited financial results for the quarter and half yearly ended September 30, 2025

pdf

Sun Pharma Advanced Research Company Ltd.

31 Oct 2025

133.51

-1.84%

Board Meeting

Sun Pharma Advanced Research Company Ltd - 532872 - Board Meeting Intimation for Approval Of Unaudited …

BSE India

Sun Pharma Advanced Research Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30, 2025

pdf

Sun Pharma Advanced Research Company Ltd.

29 Oct 2025

133.51

-1.84%

Company Update

Sun Pharma Advanced Research Company Ltd - 532872 - Clarification Regarding Increase In The Volume

BSE India

Response of Clarification sought from BSE Limited

pdf

Sun Pharma Advanced Research Company Ltd.

29 Oct 2025

133.51

-1.84%

Company Update

Sun Pharma Advanced Research Company Ltd - 532872 - Clarification sought from Sun Pharma Advanced Research Company Ltd

BSE India

The Exchange has sought clarification from Sun Pharma Advanced Research Company Ltd on October 29, 2025, with reference to Movement in Volume. The reply is awaited.